 Lantern Pharma NASDAQ: LTRN, a clinical stage biotechnology company using its proprietary RADR artificial intelligence A.I. platform to improve drug discovery and development, and identify patients who will benefit from its portfolio of targeted oncology therapeutics, today announced that an interview with its CEO and President Panna Sharma will air on The RedChip Money Report television program. The interview will air Sunday, August 16, 2020 at 6 p.m. local time on Bloomberg International, available in 100 million homes across Europe. 